Initially developed for treating type 2 diabetes, their remarkable impact on weight loss soon became apparent
Morselli, L
Data from the ORION study, presented at the Obesity Medicine Associations 2026 annual conference, showed that oral semaglutide 25 mg was associated with significantly greater mean weight loss than orforglipron in a population-adjusted indirect treatment comparison
The presence of Nrf2 and its inhibitor Keap1 in plasma is associated with damaged vascular endothelial cell-, macrophage-and other cell-associated leakage secondary to the loss of cell membrane integrity due to lipid peroxidation following chronic inflammation and oxidative stress (Kasprzak et al., 2020), and Nrf2 and Keap1 in circulation are markers of severe inflammation and oxidative stress (Tu et al., 2019)
Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS
No organ damage, no hormonal disruption, no carcinogenic signals